Annual Retained Earnings
-$515.54 M
-$51.21 M-11.03%
31 December 2023
Summary:
Aptose Biosciences annual retained earnings is currently -$515.54 million, with the most recent change of -$51.21 million (-11.03%) on 31 December 2023. During the last 3 years, it has fallen by -$158.38 million (-44.35%). APTO annual retained earnings is now -2419.55% below its all-time high of -$20.46 million, reached on 31 May 1997.APTO Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$539.38 M
-$6.95 M-1.31%
30 September 2024
Summary:
Aptose Biosciences quarterly retained earnings is currently -$539.38 million, with the most recent change of -$6.95 million (-1.31%) on 30 September 2024. Over the past year, it has dropped by -$35.80 million (-7.11%). APTO quarterly retained earnings is now -2465.76% below its all-time high of -$21.02 million, reached on 31 August 1997.APTO Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APTO Retained Earnings Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -11.0% | -7.1% |
3 y3 years | -44.4% | -35.5% |
5 y5 years | -87.0% | -83.3% |
APTO Retained Earnings High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -44.4% | at low | -35.5% | at low |
5 y | 5 years | -87.0% | at low | -83.3% | at low |
alltime | all time | -2419.6% | at low | -2465.8% | at low |
Aptose Biosciences Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -$539.38 M(+1.3%) |
June 2024 | - | -$532.43 M(+1.4%) |
Mar 2024 | - | -$525.18 M(+1.9%) |
Dec 2023 | -$515.54 M(+11.0%) | -$515.54 M(+2.4%) |
Sept 2023 | - | -$503.58 M(+2.3%) |
June 2023 | - | -$492.13 M(+3.0%) |
Mar 2023 | - | -$478.01 M(+2.9%) |
Dec 2022 | -$464.33 M(+9.9%) | -$464.33 M(+2.2%) |
Sept 2022 | - | -$454.33 M(+2.2%) |
June 2022 | - | -$444.55 M(+2.4%) |
Mar 2022 | - | -$433.99 M(+2.7%) |
Dec 2021 | -$422.51 M(+18.3%) | -$422.51 M(+6.1%) |
Sept 2021 | - | -$398.18 M(+2.9%) |
June 2021 | - | -$386.85 M(+3.6%) |
Mar 2021 | - | -$373.38 M(+4.5%) |
Dec 2020 | -$357.15 M(+18.3%) | -$357.15 M(+4.3%) |
Sept 2020 | - | -$342.44 M(+4.0%) |
June 2020 | - | -$329.19 M(+5.0%) |
Mar 2020 | - | -$313.44 M(+3.8%) |
Dec 2019 | -$301.92 M(+9.5%) | -$301.92 M(+2.6%) |
Sept 2019 | - | -$294.21 M(+2.4%) |
June 2019 | - | -$287.36 M(+2.2%) |
Mar 2019 | - | -$281.14 M(+2.0%) |
Dec 2018 | -$275.64 M(+11.7%) | -$275.64 M(+2.3%) |
Sept 2018 | - | -$269.39 M(+2.1%) |
June 2018 | - | -$263.87 M(+4.0%) |
Mar 2018 | - | -$253.60 M(+2.8%) |
Dec 2017 | -$246.77 M(+5.0%) | -$246.77 M(+16.6%) |
Sept 2017 | - | -$211.56 M(+6.2%) |
June 2017 | - | -$199.25 M(+3.8%) |
Mar 2017 | - | -$191.88 M(-18.4%) |
Dec 2016 | -$235.13 M(+6.4%) | -$235.13 M(+24.8%) |
Sept 2016 | - | -$188.33 M(+0.0%) |
June 2016 | - | -$188.28 M(+2.7%) |
Mar 2016 | - | -$183.34 M(-17.0%) |
Dec 2015 | -$220.89 M(+17.5%) | -$220.89 M(+29.8%) |
Sept 2015 | - | -$170.19 M(-6.2%) |
June 2015 | - | -$181.43 M(+3.7%) |
Mar 2015 | - | -$174.99 M(-9.0%) |
Dec 2014 | -$188.04 M(-3.1%) | - |
Sept 2014 | - | -$192.35 M(-0.9%) |
May 2014 | -$194.01 M(-0.0%) | -$194.01 M(+4.6%) |
Feb 2014 | - | -$185.40 M(-3.4%) |
Nov 2013 | - | -$192.01 M(+0.7%) |
Aug 2013 | - | -$190.72 M(-1.7%) |
May 2013 | -$194.01 M(+2.8%) | -$194.01 M(-0.0%) |
Feb 2013 | - | -$194.03 M(-2.3%) |
Nov 2012 | - | -$198.59 M(+0.8%) |
Aug 2012 | - | -$197.03 M(+4.4%) |
May 2012 | -$188.64 M(-2.9%) | -$188.64 M(-3.0%) |
Feb 2012 | - | -$194.50 M(+4.4%) |
Nov 2011 | - | -$186.29 M(-4.5%) |
Aug 2011 | - | -$195.00 M(+0.4%) |
May 2011 | -$194.28 M | -$194.28 M(+1.0%) |
Feb 2011 | - | -$192.31 M(+5.1%) |
Date | Annual | Quarterly |
---|---|---|
Nov 2010 | - | -$182.93 M(+4.7%) |
Aug 2010 | - | -$174.69 M(+0.1%) |
May 2010 | -$174.46 M(+0.4%) | -$174.46 M(+0.6%) |
Feb 2010 | - | -$173.40 M(+1.4%) |
Nov 2009 | - | -$171.05 M(+4.3%) |
Aug 2009 | - | -$164.03 M(-5.6%) |
May 2009 | -$173.77 M(-4.3%) | -$173.77 M(+17.6%) |
Feb 2009 | - | -$147.70 M(-0.9%) |
Nov 2008 | - | -$149.00 M(-13.4%) |
Aug 2008 | - | -$172.04 M(-5.3%) |
May 2008 | -$181.59 M(+11.5%) | -$181.59 M(+0.6%) |
Feb 2008 | - | -$180.49 M(+4.4%) |
Nov 2007 | - | -$172.96 M(+7.3%) |
Aug 2007 | - | -$161.15 M(-1.1%) |
May 2007 | -$162.87 M(+9.0%) | -$162.87 M(+10.5%) |
Feb 2007 | - | -$147.38 M(-1.3%) |
Nov 2006 | - | -$149.31 M(-1.4%) |
Aug 2006 | - | -$151.37 M(+1.3%) |
May 2006 | -$149.45 M(+27.9%) | -$149.45 M(+5.2%) |
Feb 2006 | - | -$142.01 M(+5.3%) |
Nov 2005 | - | -$134.84 M(+5.1%) |
Aug 2005 | - | -$128.30 M(+9.8%) |
May 2005 | -$116.86 M(+30.7%) | -$116.86 M(+1.5%) |
Feb 2005 | - | -$115.12 M(-0.1%) |
Nov 2004 | - | -$115.19 M(+15.6%) |
Aug 2004 | - | -$99.66 M(+11.5%) |
May 2004 | -$89.40 M(+34.1%) | -$89.40 M(+4.8%) |
Feb 2004 | - | -$85.31 M(+4.8%) |
Nov 2003 | - | -$81.41 M(+13.1%) |
Aug 2003 | - | -$72.00 M(+8.0%) |
May 2003 | -$66.67 M(+36.1%) | -$66.67 M(+14.1%) |
Feb 2003 | - | -$58.44 M(+10.3%) |
Nov 2002 | - | -$52.98 M(+4.6%) |
Aug 2002 | - | -$50.66 M(+3.4%) |
May 2002 | -$48.99 M(+22.7%) | -$48.99 M(+10.4%) |
Feb 2002 | - | -$44.39 M(+2.5%) |
Nov 2001 | - | -$43.31 M(+4.2%) |
Aug 2001 | - | -$41.58 M(+4.2%) |
May 2001 | -$39.92 M(+29.6%) | -$39.92 M(+11.0%) |
Feb 2001 | - | -$35.96 M(+5.1%) |
Nov 2000 | - | -$34.20 M(+3.4%) |
Aug 2000 | - | -$33.07 M(+7.3%) |
May 2000 | -$30.81 M(+20.8%) | -$30.81 M(+9.1%) |
Feb 2000 | - | -$28.26 M(+5.9%) |
Nov 1999 | - | -$26.69 M(+4.4%) |
Aug 1999 | - | -$25.56 M(+0.2%) |
May 1999 | -$25.50 M(+12.9%) | -$25.50 M(+6.0%) |
Feb 1999 | - | -$24.06 M(+4.4%) |
Nov 1998 | - | -$23.05 M(+5.9%) |
Aug 1998 | - | -$21.77 M(-3.6%) |
May 1998 | -$22.59 M(+10.4%) | -$22.59 M(-0.5%) |
Feb 1998 | - | -$22.70 M(+4.9%) |
Nov 1997 | - | -$21.64 M(+3.0%) |
Aug 1997 | - | -$21.02 M |
May 1997 | -$20.46 M | - |
FAQ
- What is Aptose Biosciences annual retained earnings?
- What is the all time high annual retained earnings for Aptose Biosciences?
- What is Aptose Biosciences annual retained earnings year-on-year change?
- What is Aptose Biosciences quarterly retained earnings?
- What is the all time high quarterly retained earnings for Aptose Biosciences?
- What is Aptose Biosciences quarterly retained earnings year-on-year change?
What is Aptose Biosciences annual retained earnings?
The current annual retained earnings of APTO is -$515.54 M
What is the all time high annual retained earnings for Aptose Biosciences?
Aptose Biosciences all-time high annual retained earnings is -$20.46 M
What is Aptose Biosciences annual retained earnings year-on-year change?
Over the past year, APTO annual retained earnings has changed by -$51.21 M (-11.03%)
What is Aptose Biosciences quarterly retained earnings?
The current quarterly retained earnings of APTO is -$539.38 M
What is the all time high quarterly retained earnings for Aptose Biosciences?
Aptose Biosciences all-time high quarterly retained earnings is -$21.02 M
What is Aptose Biosciences quarterly retained earnings year-on-year change?
Over the past year, APTO quarterly retained earnings has changed by -$35.80 M (-7.11%)